Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 3
1990 3
1991 1
1992 1
1993 2
1994 2
1995 3
1996 2
1997 9
1998 8
1999 10
2000 1
2001 3
2002 1
2003 5
2004 3
2005 2
2006 12
2007 9
2008 7
2009 14
2010 6
2011 12
2012 8
2013 13
2014 19
2015 20
2016 21
2017 16
2018 17
2019 15
2020 20
2021 19
2022 20
2023 11
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

305 results

Results by year

Filters applied: . Clear all
Page 1
Bromfenac.
[No authors listed] [No authors listed] 2018 Dec 3. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2018 Dec 3. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000016 Free Books & Documents. Review.
Use caution when using bromfenac in nursing mothers, especially with the injectable drug. Maternal use of bromfenac eye drops would not be expected to cause any adverse effects in breastfed infants. ...
Use caution when using bromfenac in nursing mothers, especially with the injectable drug. Maternal use of bromfenac eye drops …
Topical bromfenac for prevention and treatment of cystoid macular edema following cataract surgery: a review.
Sheppard JD. Sheppard JD. Clin Ophthalmol. 2016 Oct 25;10:2099-2111. doi: 10.2147/OPTH.S86971. eCollection 2016. Clin Ophthalmol. 2016. PMID: 27822006 Free PMC article. Review.
Few cases of clinical CME were observed with bromfenac use in a total of 19 reviewed studies. There were no significant differences in CME incidence between bromfenac and corticosteroid-treated patients or between bromfenac- and bromfenac plus corticos …
Few cases of clinical CME were observed with bromfenac use in a total of 19 reviewed studies. There were no significant differences i …
Bromfenac Ophthalmic Solution 0.07%: A Review of Its Use After Cataract Surgery.
Hoy SM. Hoy SM. Clin Drug Investig. 2015 Aug;35(8):525-9. doi: 10.1007/s40261-015-0309-3. Clin Drug Investig. 2015. PMID: 26177719 Review.
The nonsteroidal anti-inflammatory drug bromfenac has recently been reformulated with a lower pH to facilitate a reduction in the concentration of bromfenac (to 0.07%) while ensuring an ocular bioavailability similar to that of the 0.09% formulation. Bromfenac …
The nonsteroidal anti-inflammatory drug bromfenac has recently been reformulated with a lower pH to facilitate a reduction in the con …
Efficacy and safety of bromfenac 0.075% formulated in DuraSite for pain and inflammation in cataract surgery.
Wentz SM, Price F, Harris A, Siesky B, Ciulla T. Wentz SM, et al. Expert Opin Pharmacother. 2019 Oct;20(14):1703-1709. doi: 10.1080/14656566.2019.1645834. Epub 2019 Jul 25. Expert Opin Pharmacother. 2019. PMID: 31343372 Review.
Introduction: Bromfenac is a topical ophthalmic non-steroidal anti-inflammatory drug (NSAID) used to reduce pain and treat post-operative inflammation after cataract surgery. Bromfenac 0.075% in the DuraSite vehicle is a newly-approved formulation which has been sho …
Introduction: Bromfenac is a topical ophthalmic non-steroidal anti-inflammatory drug (NSAID) used to reduce pain and treat post-opera …
Bromfenac-induced neurotrophic keratitis in a corneal graft.
Raj N, Panigrahi A, Alam M, Gupta N. Raj N, et al. BMJ Case Rep. 2022 Jul 11;15(7):e249400. doi: 10.1136/bcr-2022-249400. BMJ Case Rep. 2022. PMID: 35817488 Free PMC article.
On checking his medications, it was found that the patient was unknowingly using bromfenac drops in place of brimonidine tartrate for the past month. A diagnosis of neurotrophic keratitis was made in the setting of PK performed for viral keratitis, incited by use of topica …
On checking his medications, it was found that the patient was unknowingly using bromfenac drops in place of brimonidine tartrate for …
Clinical pharmacokinetics and pharmacodynamics of bromfenac.
Skjodt NM, Davies NM. Skjodt NM, et al. Clin Pharmacokinet. 1999 Jun;36(6):399-408. doi: 10.2165/00003088-199936060-00002. Clin Pharmacokinet. 1999. PMID: 10427465 Review.
Bromfenac is a nonsteroidal anti-inflammatory drug whose peak plasma concentration is reached 0.5 hours after oral administration. ...Renal disease, hepatic disease and aging alter the disposition kinetics of bromfenac, and dosage adjustment may be advisable. Bro …
Bromfenac is a nonsteroidal anti-inflammatory drug whose peak plasma concentration is reached 0.5 hours after oral administration. .. …
Bromfenac 0.09% for the Treatment of Macular Edema Secondary to Noninfectious Uveitis.
Saade JS, Istambouli R, AbdulAal M, Antonios R, Hamam RN. Saade JS, et al. Middle East Afr J Ophthalmol. 2021 Sep 25;28(2):98-103. doi: 10.4103/meajo.meajo_134_21. eCollection 2021 Apr-Jun. Middle East Afr J Ophthalmol. 2021. PMID: 34759667 Free PMC article.
The aim of the study is to assess the efficacy of bromfenac sodium solution in the treatment of UME. METHODS: The charts of 10 patients with macular edema due to noninfectious uveitis treated with bromfenac 0.09% were reviewed retrospectively. ...RESULTS: Twelve eye …
The aim of the study is to assess the efficacy of bromfenac sodium solution in the treatment of UME. METHODS: The charts of 10 patien …
Bromfenac ophthalmic solution for the treatment of postoperative ocular pain and inflammation: safety, efficacy, and patient adherence.
Rajpal RK, Ross B, Rajpal SD, Hoang K. Rajpal RK, et al. Patient Prefer Adherence. 2014 Jun 25;8:925-31. doi: 10.2147/PPA.S46667. eCollection 2014. Patient Prefer Adherence. 2014. PMID: 25028541 Free PMC article. Review.
The evolution of bromfenac ophthalmic solution over the years has involved either lowering the concentration of the active ingredient or extending the dosing interval to improve patient adherence/compliance. This review will focus on the history and progression of bromf …
The evolution of bromfenac ophthalmic solution over the years has involved either lowering the concentration of the active ingredient …
Ophthalmic utility of topical bromfenac, a twice-daily nonsteroidal anti-inflammatory agent.
Jones J, Francis P. Jones J, et al. Expert Opin Pharmacother. 2009 Oct;10(14):2379-85. doi: 10.1517/14656560903188425. Expert Opin Pharmacother. 2009. PMID: 19735215 Review.
Adverse events associated with use have been minimal in large studies, although there are reports of corneal compromise with bromfenac use in cases of preexisting corneal disease. The comfort and reduced frequency of use offered by bromfenac would be expected to imp …
Adverse events associated with use have been minimal in large studies, although there are reports of corneal compromise with bromfenac …
Bromfenac Inhibits TGF-beta1-Induced Fibrotic Effects in Human Pterygium and Conjunctival Fibroblasts.
Chen K, Lai K, Zhang X, Qin Z, Fu Q, Luo C, Jin X, Hu J, Liu S, Yao K. Chen K, et al. Invest Ophthalmol Vis Sci. 2019 Mar 1;60(4):1156-1164. doi: 10.1167/iovs.18-24743. Invest Ophthalmol Vis Sci. 2019. PMID: 30908581
The aims of the present in vitro study were to investigate the antifibrotic effects of bromfenac (a kind of NSAID) on primary human pterygium fibroblasts (HPFs) and primary human conjunctival fibroblasts (HConFs), as well as to explore the possible mechanisms of these effe …
The aims of the present in vitro study were to investigate the antifibrotic effects of bromfenac (a kind of NSAID) on primary human p …
305 results